<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04323982</url>
  </required_header>
  <id_info>
    <org_study_id>CCPMOH2020-China-1</org_study_id>
    <nct_id>NCT04323982</nct_id>
  </id_info>
  <brief_title>Comparison of Traditional Cataract Surgery and Traditional Surgery Combined Triamcinolone Staining</brief_title>
  <official_title>Comparison of Traditional Cataract Surgery and Traditional Surgery Combine Triamcinolone Staining of the Anterior Vitreous in Treating Congenital Cataracts</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sun Yat-sen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Previously, the investigators have developed a surgical technique to reduce inflammatory
      response after congenital cataract surgery. This prospective, randomized controlled study
      aims to compare the prognosis of traditional cataract surgery with traditional surgery
      combined triamcinolone staining of the anterior vitreous in treating congenital cataracts.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Surgical technique for congenital cataract is now more and more mature, but many young
      patients still have obvious postoperative inflammatory response, which might cause visual
      axial opacification, posterior synechiae and secondary glaucoma. Triamcinolone is used in
      intraocular injection for its anti-inflammatory effect However, the application of
      Triamcinolone was reported to be associated with high intraocular pressure. It is necessary
      to evaluate the safety and effectiveness of using triamcinolone in congenital cataract
      surgery.

      In this randomized clinical trial, children with equal degree of congenital cataract in both
      eyesare enrolled. Patients receive cataract surgery on both eyes on the same day. For each
      patient, one eye is randomly assigned to undergo traditional surgical procedure, while the
      fellow eye is undergoing new surgical procedure. The traditional surgical procedure include
      anterior continuous curvilinear capsulorhexis (ACCC), irrigation/aspiration (I/A), posterior
      continuous curvilinear capsulorhexis (PCCC), and anterior vitrectomy(A-VIT). Primary
      intraocular lens implantation (IOL) is performed in children older than age of two. The new
      surgical procedure is to combine triamcinolone staining of the anterior vitreous on the basis
      of the traditional surgical procedure. Investigators then compare the incidence of high
      intraocular pressure, visual axis opacification, uveitis, iris/pupil abnormality, and macular
      edema between two groups
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 27, 2020</start_date>
  <completion_date type="Anticipated">March 25, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 25, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>incidence of high intraocular pressure</measure>
    <time_frame>5 years</time_frame>
    <description>Determined with the Tono-pen.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>incidence of visual axis opacification</measure>
    <time_frame>5 years</time_frame>
    <description>Visual axis obscuration will be evaluated based on the retroillumination.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>incidence of uveitis and iris/pupil abnormality</measure>
    <time_frame>5 years</time_frame>
    <description>Uveitis and iris/pupil abnormality will be evaluated based on the slip lamp examination.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Best corrected visual acuity</measure>
    <time_frame>5 years</time_frame>
    <description>Determined with the Teller's acuity card, the Lea symbol visual acuity chart or the ETDRS chart according the patient's age.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Central corneal thickness</measure>
    <time_frame>5 years</time_frame>
    <description>Determined with the pentacam.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Central macular thickness</measure>
    <time_frame>5 years</time_frame>
    <description>Determined with the optical coherence tomography.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Congenital Cataract</condition>
  <arm_group>
    <arm_group_label>New Cataract Surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Traditional surgery combined triamcinolone staining of the anterior vitreous (TA)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Traditional Cataract Surgery</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>For patients younger than 2 years of age: anterior continuous capsulorhexis + irrigation/aspiration + posterior capsulorhexis + anterior vitrectomy (ACCC+ I/A + PCCC + A-vit) For patients older than 2years of age: anterior continuous capsulorhexis + irrigation/aspiration + posterior capsulorhexis + primary intraocular lens implantation + anterior vitrectomy (ACCC+ I/A + PCCC + IOL + A-vit)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>new surgical procedure</intervention_name>
    <description>（ACCC + I / A + PCCC + TA+ A-vit) or （ACCC + I / A + PCCC + IOL + TA + A-vit）</description>
    <arm_group_label>New Cataract Surgery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>traditional surgical procedure</intervention_name>
    <description>（ACCC + I / A + PCCC + A-vit) or （ACCC + I / A + PCCC + IOL + A-vit）</description>
    <arm_group_label>Traditional Cataract Surgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age between 3 months and 13 years

          2. Uncomplicated bilateral same degree of congenital cataract (≥ 3 mm central dense
             opacity)

          3. Informed consent signed by a parent or legal guardian

        Exclusion Criteria:

          1. Intraocular pressure &gt;21 mmHg

          2. Preterm birth (&lt;28 weeks)

          3. Presence of other ocular diseases (keratitis, keratoleukoma, aniridia, glaucoma,
             microcornea, persistent hyperplastic primary vitreous) or systemic disease (congenital
             heart disease, ischemic encephalopathy)

          4. History of ocular trauma

          5. Previous intraocular surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Months</minimum_age>
    <maximum_age>13 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chen Weirong, MD</last_name>
    <role>Study Chair</role>
    <affiliation>SunYat-sen University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wang Qiwei, MD</last_name>
    <phone>+86-13924025677</phone>
    <email>wang_qiwei@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Zhognshan Ophthalmic Center, Sun Yat-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510060</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Qiwei Wang, M.D., Ph.D</last_name>
      <phone>+ 86-13924025677</phone>
      <email>wang_qiwei@126.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <link>
    <url>http://www.gzzoc.com/</url>
    <description>Homepage of Zhongshan Ophthalmic Center</description>
  </link>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>March 25, 2020</study_first_submitted>
  <study_first_submitted_qc>March 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 27, 2020</study_first_posted>
  <last_update_submitted>June 2, 2020</last_update_submitted>
  <last_update_submitted_qc>June 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sun Yat-sen University</investigator_affiliation>
    <investigator_full_name>Haotian Lin</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>congenital cataract, Triamcinolone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

